Cell Therapy

Immune cell therapies and stem cell therapies are receiving increasing amounts of attention for their potential use as treatments for pathologies that include cancer, immune disorders, and cardiovascular disease. Perhaps the most attention has focused on cancer T cell therapies where the patient's own cells are used in the treatment. A common workflow includes enrichment of the cells of interest followed by genetic modifications and ex vivo expansion of the cells. The cells, now reprogrammed for enhanced anti-tumor activity, are then re-introduced into the patient. Some cell types used for immune cell therapy include tumor-infiltrating lymphocytes (TILs), transgenic TCR T cells, and chimeric antigen receptor (CAR) T cells. R&D Systems offers reagents and kits for every step of the cell therapy workflow.